{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:11:46Z","timestamp":1771953106325,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T00:00:00Z","timestamp":1547424000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1038\/s41401-018-0200-x","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T08:24:48Z","timestamp":1547454288000},"page":"1095-1105","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Discovery of \u03b2-arrestin-biased \u03b22-adrenoceptor agonists from 2-amino-2-phenylethanol derivatives"],"prefix":"10.1038","volume":"40","author":[{"given":"Anthony Yiu-Ho","family":"Woo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-yue","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-mei","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-juan","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-ran","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irving W.","family":"Wainer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao-sheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-ping","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,14]]},"reference":[{"key":"200_CR1","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nrd2199","volume":"5","author":"JP Overington","year":"2006","unstructured":"Overington JP, Al-Lazikani B, Hopkins AL. How many drug targets are there? Nat Rev Drug Discov. 2006;5:993\u20136.","journal-title":"Nat Rev Drug Discov"},{"key":"200_CR2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.tips.2007.06.009","volume":"28","author":"T Kenakin","year":"2007","unstructured":"Kenakin T. Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors. Trends Pharmacol Sci. 2007;28:407\u201315.","journal-title":"Trends Pharmacol Sci"},{"key":"200_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104463","volume":"320","author":"JD Urban","year":"2007","unstructured":"Urban JD, Clarke WP,\u00a0von Zastrow M,\u00a0Nichols DE,\u00a0Kobilka B,\u00a0Weinstein H, et al. Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther. 2007;320:1\u201313.","journal-title":"J Pharmacol Exp Ther"},{"key":"200_CR4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.tips.2007.06.002","volume":"28","author":"RB Mailman","year":"2007","unstructured":"Mailman RB. GPCR functional selectivity has therapeutic impact. Trends Pharmacol Sci. 2007;28:390\u20136.","journal-title":"Trends Pharmacol Sci"},{"key":"200_CR5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1124\/mol.108.052944","volume":"75","author":"R Seifert","year":"2009","unstructured":"Seifert R, Dove S. Functional selectivity of GPCR ligand stereoisomers: new pharmacological opportunities. Mol Pharmacol. 2009;75:13\u201318.","journal-title":"Mol Pharmacol"},{"key":"200_CR6","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/j.1476-5381.2009.00602.x","volume":"159","author":"BA Evans","year":"2010","unstructured":"Evans BA, Sato M, Sarwar M, Hutchinson DS, Summers RJ. Ligand-directed signalling at beta-adrenoceptors. Br J Pharmacol. 2010;159:1022\u201338.","journal-title":"Br J Pharmacol"},{"key":"200_CR7","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.tips.2007.06.006","volume":"28","author":"JD Violin","year":"2007","unstructured":"Violin JD, Lefkowitz RJ. \u03b2-Arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol Sci. 2007;28:416\u201322.","journal-title":"Trends Pharmacol Sci"},{"key":"200_CR8","doi-asserted-by":"crossref","first-page":"16657","DOI":"10.1073\/pnas.0707936104","volume":"104","author":"JW Wisler","year":"2007","unstructured":"Wisler JW, DeWire SM,\u00a0Whalen EJ,\u00a0Violin JD,\u00a0Drake MT,\u00a0Ahn S, et al. A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling. Proc Natl Acad Sci U S A. 2007;104:16657\u201362.","journal-title":"Proc Natl Acad Sci USA"},{"key":"200_CR9","doi-asserted-by":"crossref","first-page":"14555","DOI":"10.1073\/pnas.0804745105","volume":"105","author":"IM Kim","year":"2008","unstructured":"Kim IM, Tilley DG,\u00a0Chen J,\u00a0Salazar NC,\u00a0Whalen EJ,\u00a0Violin JD, et al. A beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation. Proc Natl Acad Sci U S A. 2008;105:14555\u201360.","journal-title":"Proc Natl Acad Sci USA"},{"key":"200_CR10","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1073\/pnas.96.12.7059","volume":"96","author":"S Engelhardt","year":"1999","unstructured":"Engelhardt S, Hein L, Wiesmann F, Lohse MJ. Progressive hypertrophy and heart failure in \u03b21-adrenergic receptor transgenic mice. Proc Natl Acad Sci U S A. 1999;96:7059\u201364.","journal-title":"Proc Natl Acad Sci USA"},{"key":"200_CR11","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1006\/jmcc.2000.1123","volume":"32","author":"JD Bisognano","year":"2000","unstructured":"Bisognano JD, Weinberger HD,\u00a0Bohlmeyer TJ,\u00a0Pende A,\u00a0Raynolds MV,\u00a0Sastravaha A, et al. Myocardial-directed overexpression of the human \u03b21-adrenergic receptor in transgenic mice. J Mol Cell Cardiol. 2000;32:817\u201330.","journal-title":"J Mol Cell Cardiol"},{"key":"200_CR12","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1073\/pnas.98.4.1607","volume":"98","author":"WZ Zhu","year":"2001","unstructured":"Zhu WZ, Zheng M,\u00a0Koch WJ,\u00a0Lefkowitz RJ,\u00a0Kobilka BK,\u00a0Xiao RP. Dual modulation of cell survival and cell death by \u03b22-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci U S A. 2001;98:1607\u201312.","journal-title":"Proc Natl Acad Sci USA"},{"key":"200_CR13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1172\/JCI200316326","volume":"111","author":"WZ Zhu","year":"2003","unstructured":"Zhu WZ, Wang SQ,\u00a0Chakir K,\u00a0Yang D,\u00a0Zhang T,\u00a0Brown JH, et al. Linkage of \u03b21-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+\/calmodulin kinase II. J Clin Invest. 2003;111:617\u201325.","journal-title":"J Clin Invest"},{"key":"200_CR14","first-page":"322","volume":"47","author":"RP Xiao","year":"1995","unstructured":"Xiao RP, Ji X, Lakatta EG. Functional coupling of the \u03b22-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol Pharmacol. 1995;47:322\u20139.","journal-title":"Mol Pharmacol"},{"key":"200_CR15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/jmcc.1994.1017","volume":"26","author":"M B\u00f6hm","year":"1994","unstructured":"B\u00f6hm M, Eschenhagen T, Gierschik P, Larisch K, Lensche H, Mende U, et al. Radioimmunochemical quantification of Gi\u03b1 in right and left ventricles from patients with ischaemic and dilated cardiomyopathy and predominant left ventricular failure. J Mol Cell Cardiol. 1994;26:133\u201349.","journal-title":"J Mol Cell Cardiol"},{"key":"200_CR16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1172\/JCI113569","volume":"82","author":"AM Feldman","year":"1988","unstructured":"Feldman AM, Cates AE,\u00a0Veazey WB,\u00a0Hershberger RE,\u00a0Bristow MR,\u00a0Baughman KL, et al. Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest. 1988;82:189\u201397.","journal-title":"J Clin Invest"},{"key":"200_CR17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/CIRCRESAHA.111.253260","volume":"110","author":"W Zhu","year":"2012","unstructured":"Zhu W, Petrashevskaya N,\u00a0Ren S,\u00a0Zhao A,\u00a0Chakir K,\u00a0Gao E, et al. Gi-biased \u03b22AR signaling links GRK2 upregulation to heart failure. Circ Res. 2012;110:265\u201374.","journal-title":"Circ Res"},{"key":"200_CR18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.yjmcc.2003.09.010","volume":"36","author":"M Sato","year":"2004","unstructured":"Sato M, Gong H, Terracciano CM, Ranu H, Harding SE. Loss of \u03b2-adrenoceptor response in myocytes overexpressing the Na+\/Ca2+-exchanger. J Mol Cell Cardiol. 2004;36:43\u201348.","journal-title":"J Mol Cell Cardiol"},{"key":"200_CR19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.yjmcc.2003.10.013","volume":"36","author":"RP Xiao","year":"2004","unstructured":"Xiao RP, Balke CW. Na+\/Ca2+ exchange linking beta2-adrenergic Gi signaling to heart failure: associated defect of adrenergic contractile support. J Mol Cell Cardiol. 2004;36:7\u201311.","journal-title":"J Mol Cell Cardiol"},{"key":"200_CR20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/01.RES.0000184615.56822.bd","volume":"97","author":"W Zhu","year":"2005","unstructured":"Zhu W, Zeng X, Zheng M, Xiao RP. The enigma of beta2-adrenergic receptor Gi signaling in the heart: the good, the bad, and the ugly. Circ Res. 2005;97:507\u20139.","journal-title":"Circ Res"},{"key":"200_CR21","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1161\/01.CIR.0000087595.17277.73","volume":"108","author":"RP Xiao","year":"2003","unstructured":"Xiao RP, \u00a0Zhang SJ,\u00a0Chakir K,\u00a0Avdonin P,\u00a0Zhu W,\u00a0Bond RA, et al. Enhanced Gi signaling selectively negates \u03b22-AR\u2013 but not \u03b21-AR\u2013mediated positive inotropic effect in myocytes from failing rat hearts. Circulation. 2003;108:1633\u20139.","journal-title":"Circulation"},{"key":"200_CR22","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/01.CIR.0000139844.15045.F9","volume":"110","author":"I Ahmet","year":"2004","unstructured":"Ahmet I, Krawczyk M,\u00a0Heller P,\u00a0Moon C,\u00a0Lakatta EG,\u00a0Talan MI. Beneficial effects of chronic pharmacological manipulation of \u03b2-adrenoceptor subtype signaling in rodent dilated ischemic cardiomyopathy. Circulation. 2004;110:1083\u201399.","journal-title":"Circulation"},{"key":"200_CR23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10741-005-7543-3","volume":"10","author":"I Ahmet","year":"2005","unstructured":"Ahmet I, Lakatta EG, Talan M. Pharmacological stimulation of \u03b22-adrenergic receptors (\u03b22AR) enhances therapeutic effectiveness of \u03b21AR blockade in rodent dilated ischemic cardiomyopathy. Heart Fail Rev. 2005;10:289\u201396.","journal-title":"Heart Fail Rev"},{"key":"200_CR24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1124\/jpet.107.135335","volume":"325","author":"I Ahmet","year":"2008","unstructured":"Ahmet I, Krawczyk M, Zhu W, Woo AY, Morrell C, Poosala S, et al. Cardioprotective and survival benefits of long-term combined therapy with \u03b22AR agonist and \u03b21AR blocker in dilated cardiomyopathy post-myocardial infarction. J Pharmacol Exp Ther. 2008;325:491\u20139.","journal-title":"J Pharmacol Exp Ther"},{"key":"200_CR25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1124\/jpet.109.157107","volume":"331","author":"I Ahmet","year":"2009","unstructured":"Ahmet I, Morrell C, Lakatta EG, Talan MI. Therapeutic efficacy of a combination of a beta1-adrenoreceptor (AR) blocker and beta2-AR agonist in a rat model of postmyocardial infarction dilated heart failure exceeds that of a beta1-AR blocker plus angiotensin-converting enzyme inhibitor. J Pharmacol Exp Ther. 2009;331:178\u201385.","journal-title":"J Pharmacol Exp Ther"},{"issue":"100","key":"200_CR26","doi-asserted-by":"crossref","first-page":"100ra88","DOI":"10.1126\/scitranslmed.3001909","volume":"3","author":"K Chakir","year":"2011","unstructured":"Chakir K, Depry C,\u00a0Dimaano VL,\u00a0Zhu WZ,\u00a0Vanderheyden M,\u00a0Bartunek J, et al. Galphas-biased beta2-adrenergic receptor signaling from restoring synchronous contraction in the failing heart. Sci Transl Med. 2011;3(100):100ra88.","journal-title":"Sci Transl Med"},{"key":"200_CR27","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1111\/bph.12965","volume":"172","author":"AY Woo","year":"2015","unstructured":"Woo AY, Song Y, Xiao RP, Zhu W. Biased \u03b22-adrenoceptor signalling: pathophysiology and drug discovery. Br J Pharmacol. 2015;172:5444\u201356.","journal-title":"Br J Pharmacol"},{"key":"200_CR28","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/chir.20317","volume":"18","author":"F Beigi","year":"2006","unstructured":"Beigi F, Bertucci C,\u00a0Zhu W,\u00a0Chakir K,\u00a0Wainer IW,\u00a0Xiao RP, et al. Enantioselective separation and online affinity chromatographic characterization of R,R- and S,S-fenoterol. Chirality. 2006;18:822\u20137.","journal-title":"Chirality"},{"key":"200_CR29","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1021\/jm070030d","volume":"50","author":"K Jozwiak","year":"2007","unstructured":"Jozwiak K, Khalid C,\u00a0Tanga MJ,\u00a0Berzetei-Gurske I,\u00a0Jimenez L,\u00a0Kozocas JA, et al. Comparative molecular field analysis of the binding of the stereoisomers of fenoterol and fenoterol derivatives to the \u03b22 adrenergic receptor. J Med Chem. 2007;50:2903\u201315.","journal-title":"J Med Chem"},{"key":"200_CR30","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.bmc.2009.11.062","volume":"18","author":"K Jozwiak","year":"2010","unstructured":"Jozwiak K, Woo AY, Tanga MJ, Toll L, Jimenez L, Kozocas JA, et al. Comparative molecular field analysis of fenoterol derivatives: a platform towards highly selective and effective \u03b22-adrenergic receptor agonists. Bioorg Med Chem. 2010;18:728\u201336.","journal-title":"Bioorg Med Chem"},{"key":"200_CR31","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bmc.2013.11.030","volume":"22","author":"A Plazinska","year":"2014","unstructured":"Plazinska A, Pajak K, Rutkowska E, Jimenez L, Kozocas J, Koolpe G, et al. Comparative molecular field analysis of fenoterol derivatives interacting with an agonist-stabilized form of the \u03b22-adrenergic receptor. Bioorg Med Chem. 2014;22:234\u201346.","journal-title":"Bioorg Med Chem"},{"key":"200_CR32","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1124\/mol.108.051078","volume":"75","author":"AY Woo","year":"2009","unstructured":"Woo AY, Wang TB,\u00a0Zeng X,\u00a0Zhu W,\u00a0Abernethy DR,\u00a0Wainer IW, et al. Stereochemistry of an agonist determines coupling preference of \u03b22-adrenoceptor to different G proteins in cardiomyocytes. Mol Pharmacol. 2009;75:158\u201365.","journal-title":"Mol Pharmacol"},{"key":"200_CR33","doi-asserted-by":"crossref","first-page":"19351","DOI":"10.1074\/jbc.M114.558882","volume":"289","author":"AY Woo","year":"2014","unstructured":"Woo AY, Jozwiak K,\u00a0Toll L,\u00a0Tanga MJ,\u00a0Kozocas JA,\u00a0Jimenez L, et al. Tyrosine 308 is necessary for ligand-directed Gs protein-biased signaling of \u03b22-adrenoceptor. J Biol Chem. 2014;289:19351\u201363.","journal-title":"J Biol Chem"},{"key":"200_CR34","first-page":"94","volume":"19","author":"RJ Xing","year":"2009","unstructured":"Xing RJ, Pan L, Wen X, Ge DD, Zhang YY, Cheng MS. Synthesis and anti-asthma activities of phenylethanolamine derivatives. Chin J Med Chem. 2009;19:94\u201398. (Chinese).","journal-title":"Chin J Med Chem"},{"key":"200_CR35","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3892\/br.2014.279","volume":"2","author":"H Pan","year":"2014","unstructured":"Pan H, Li Q,\u00a0Pan L,\u00a0Liu X,\u00a0Pan L,\u00a0Zhang X, et al. Stereoselective activity of 2-(4-amino-3-chloro-5-trifluomethyl-phenyl)-2-tert-butylamino-ethanol hydrochloride to improve the pulmonary function in asthma. Biomed Rep. 2014;2:539\u201344.","journal-title":"Biomed Rep"},{"key":"200_CR36","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejmech.2018.04.041","volume":"152","author":"X Ge","year":"2018","unstructured":"Ge X, Woo AY,\u00a0Xing G,\u00a0Lu Y,\u00a0Mo Y,\u00a0Zhao Y, et al. Synthesis and biological evaluation of \u03b2(2)-adrenoceptor agonists bearing the 2-amino-2-phenylethanol scaffold. Eur J Med Chem. 2018;152:424\u201335.","journal-title":"Eur J Med Chem"},{"key":"200_CR37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bioorg.2018.04.017","volume":"79","author":"X Ge","year":"2018","unstructured":"Ge X, Mo Y,\u00a0Xing G,\u00a0Ji L,\u00a0Zhao H,\u00a0Chen J, et al. Synthesis, biological evaluation and molecular modeling of 2-amino-2-phenylethanol derivatives as novel \u03b2(2)-adrenoceptor agonists. Bioorg Chem. 2018;79:155\u201362.","journal-title":"Bioorg Chem"},{"key":"200_CR38","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1124\/mol.113.088880","volume":"85","author":"ET Westhuizen Van der","year":"2014","unstructured":"Van der Westhuizen ET, Breton B, Christopoulos A, Bouvier M. Quantification of ligand bias for clinically relevant \u03b22-adrenergic receptor ligands: implications for drug taxonomy. Mol Pharmacol. 2014;85:492\u2013509.","journal-title":"Mol Pharmacol"},{"key":"200_CR39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1098\/rspb.1983.0093","volume":"220","author":"JW Black","year":"1983","unstructured":"Black JW, Leff P. Operational models of pharmacological agonism. Proc R Soc Lond B Biol Sci. 1983;220:141\u201362.","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"200_CR40","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1124\/mol.62.5.1094","volume":"62","author":"J Friedman","year":"2002","unstructured":"Friedman J, Babu B, Clark RB. \u03b22-Arenergic receptor lacking the cyclic AMP-dependent protein kinase consensus sites fully activates extracellular signal-regulated kinase 1\/2 in human embryonic kidney 293 cells: lack of evidence for Gs\/Gi switching. Mol Pharmacol. 2002;62:1094\u2013102.","journal-title":"Mol Pharmacol"},{"key":"200_CR41","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1172\/JCI31901","volume":"117","author":"T Noma","year":"2007","unstructured":"Noma T, \u00a0Lemaire A,\u00a0Naga Prasad SV,\u00a0Barki-Harrington L,\u00a0Tilley DG,\u00a0Chen J, et al. \u03b2-arrestin-mediated \u03b21-adrenergic receptor transactivation of the EGFR confers cardioprotection. J Clin Invest. 2007;117:2445\u201358.","journal-title":"J Clin Invest"},{"key":"200_CR42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00210-014-1054-5","volume":"388","author":"MT Reinartz","year":"2015","unstructured":"Reinartz MT, K\u00e4lble S,\u00a0Littmann T,\u00a0Ozawa T,\u00a0Dove S,\u00a0Kaever V, et al. Structure-bias relationships for fenoterol stereoisomers in six molecular and cellular assays at the \u03b22-adrenoceptor. Naunyn-Schmiedeberg\u2019s Arch Pharmacol. 2015;388:51\u201365.","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"200_CR43","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00210-015-1086-5","volume":"388","author":"MT Reinartz","year":"2015","unstructured":"Reinartz MT, K\u00e4lble S, Wainer IW, Seifert R. Interaction of fenoterol stereoisomers with \u03b22-adrenoceptor-Gs\u03b1 fusion proteins: antagonist and agonist competition binding. Naunyn-Schmiedeberg\u2019s Arch Pharmacol. 2015;388:517\u201324.","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"200_CR44","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1124\/jpet.115.227959","volume":"355","author":"T Littmann","year":"2015","unstructured":"Littmann T, G\u00f6ttle M,\u00a0Reinartz MT,\u00a0K\u00e4lble S,\u00a0Wainer IW,\u00a0Ozawa T, et al. Recruitment of \u03b2-arrestin 1 and 2 to the \u03b22-adrenoceptor: analysis of 65 ligands. J Pharmacol Exp Ther. 2015;355:183\u201390.","journal-title":"J Pharmacol Exp Ther"},{"key":"200_CR45","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1124\/mol.111.072801","volume":"80","author":"S Rajagopal","year":"2011","unstructured":"Rajagopal S, Ahn S, Rominger DH, Gowen-MacDonald W, Lam CM, Dewire SM,\u00a0et al. Quantifying ligand bias at seven-transmembrane receptors. Mol Pharmacol. 2011;80:367\u201377.","journal-title":"Mol Pharmacol"},{"key":"200_CR46","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1126\/science.1109237","volume":"308","author":"RJ Lefkowitz","year":"2005","unstructured":"Lefkowitz RJ, Shenoy SK. Transduction of receptor signals by \u03b2-arrestins. Science. 2005;308:512\u20137.","journal-title":"Science"},{"key":"200_CR47","doi-asserted-by":"crossref","first-page":"pii:eaal3395","DOI":"10.1126\/scisignal.aal3395","volume":"10","author":"M O\u2019Hayre","year":"2017","unstructured":"O\u2019Hayre M, Eichel K,\u00a0Avino S,\u00a0Zhao X,\u00a0Steffen DJ,\u00a0Feng X, et al. Genetic evidence that \u03b2-arrestins are dispensable for the initiation of \u03b22-adrenergic receptor signaling to ERK. Sci Signal. 2017;10:pii:eaal3395.","journal-title":"Sci Signal"},{"key":"200_CR48","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/mol.114.096800","volume":"87","author":"LE Gimenez","year":"2015","unstructured":"Gimenez LE, Baameur F, Vayttaden SJ, Clark RB. Salmeterol efficacy and bias in the activation and kinase-mediated desensitization of \u03b22-adrenergic receptors. Mol Pharmacol. 2015;87:954\u201364.","journal-title":"Mol Pharmacol"},{"key":"200_CR49","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1165\/rcmb.2006-0158OC","volume":"36","author":"RH Moore","year":"2007","unstructured":"Moore RH, Millman EE,\u00a0Godines V,\u00a0Hanania NA,\u00a0Tran TM,\u00a0Peng H, et al. Salmeterol stimulation dissociates beta2-adrenergic receptor phosphorylation and internalization. Am J Respir Cell Mol Biol. 2007;36:254\u201361.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"200_CR50","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1074\/jbc.M506576200","volume":"281","author":"SK Shenoy","year":"2006","unstructured":"Shenoy SK, Drake MT,\u00a0Nelson CD,\u00a0Houtz DA,\u00a0Xiao K,\u00a0Madabushi S, et al. \u03b2-arrestin-dependent, G protein-independent ERK1\/2 activation by the \u03b22 adrenergic receptor. J Biol Chem. 2006;281:1261\u201373.","journal-title":"J Biol Chem"},{"key":"200_CR51","volume":"8","author":"J Wang","year":"2017","unstructured":"Wang J, Hanada K, Staus DP, Makara MA, Dahal GR, Chen Q, et al. G\u03b1(i) is required for carvedilol-induced \u03b21 adrenergic receptor \u03b2-arrestin biased signaling. Nat Commun. 2017;8:1706.","journal-title":"Nat Commun"},{"key":"200_CR52","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02661-3","volume":"9","author":"M Grundmann","year":"2018","unstructured":"Grundmann M, Merten N,\u00a0Malfacini D,\u00a0Inoue A,\u00a0Preis P,\u00a0Simon K, et al. Lack of beta-arrestin signaling in the absence of active G proteins. Nat Commun. 2018;9:341.","journal-title":"Nat Commun"},{"key":"200_CR53","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature10361","volume":"477","author":"SG Rasmussen","year":"2011","unstructured":"Rasmussen SG, \u00a0DeVree BT, Zou Y, Kruse AC, Chung KY, Kobilka TS, et al. Crystal structure of the beta2 adrenergic receptor-Gs protein complex. Nature. 2011;477:549\u201355.","journal-title":"Nature"},{"key":"200_CR54","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1021\/cb400103f","volume":"8","author":"DR Weiss","year":"2013","unstructured":"Weiss DR, Ahn S,\u00a0Sassano MF,\u00a0Kleist A,\u00a0Zhu X,\u00a0Strachan R,\u00a0et al. Conformation guides molecular efficacy in docking screens of activated \u03b2-2 adrenergic G protein coupled receptor. ACS Chem Biol. 2013;8:1018\u201326.","journal-title":"ACS Chem Biol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0200-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0200-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-018-0200-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:01:43Z","timestamp":1684616503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-018-0200-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,14]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["200"],"URL":"https:\/\/doi.org\/10.1038\/s41401-018-0200-x","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,14]]},"assertion":[{"value":"5 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}